LNZ101

Aceclidine/Brimonidine · LENZ Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LNZ101, covering 2024-09-05 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia [Phase 3]